Showing results (1-10 of 588) with videos related to
Sort By:
Pageof 59
Expert Review of Anticancer Therapy|May 19, 2009
Molecular-targeted therapy in malignant melanomaRyan J Sullivan, Michael B AtkinsExpert Opinion on Investigational Drugs|August 7, 2010
Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyondRyan J Sullivan, Michael B AtkinsMethods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Emerging clinical issues in melanoma in the molecularly targeted eraRyan J Sullivan, Michael B AtkinsMelanoma Research|September 9, 2010
Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanomaAmy Frankenthaler, Ryan J Sullivan, Wei Wang, et al.Melanoma Research|May 5, 2011
Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanomaErin R DeRose, Alexander Pleet, Wei Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Cytokine-based therapy and biochemotherapy for advanced melanomaMichael B AtkinsMedical Oncology (Northwood, London, England)|January 24, 2009
Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapyMichael B AtkinsCancer Discovery|May 3, 2018
Dual MAPK/CDK Targeting in Melanoma: New Approaches, New ChallengesRyan J SullivanSeminars in Cutaneous Medicine and Surgery|July 25, 2018
The role of targeted therapy for melanoma in the immunotherapy eraRyan J SullivanPageof 59